menu search

APVO / Why Are Aptevo Therapeutics Shares Trading Higher Today?

Why Are Aptevo Therapeutics Shares Trading Higher Today?
Aptevo Therapeutics Inc APVO earned a $10 million non-dilutive milestone payment related to 2021 sales of Ruxience, under the terms of its royalty purchase agreement with HealthCare Royalty Management LLC. Get the Inside Access Traders Are Using to Profit More and Win Bigger. Read More
Posted: Feb 9 2022, 14:28
Author Name: Benzinga
Views: 042276

APVO News  

Aptevo to Present at Bio-Europe Conference

By Accesswire
November 1, 2023

Aptevo to Present at Bio-Europe Conference

SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing nov more_horizontal

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes

By InvestorPlace
July 30, 2023

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes

Millionaire-maker penny stocks, as you might guess from the title does not represent a universally accessible sector. While these ideas can possibly m more_horizontal

Why Did Aptevo Therapeutics Stock Jump 25% Today?

By Benzinga
March 24, 2022

Why Did Aptevo Therapeutics Stock Jump 25% Today?

Aptevo Therapeutics Inc (NASDAQ: APVO) shares are trading higher Thursday after the company reported 2021 financial results.  Aptevo said royalty r more_horizontal

Why Are Aptevo Therapeutics Shares Trading Higher Today?

By Benzinga
February 9, 2022

Why Are Aptevo Therapeutics Shares Trading Higher Today?

Aptevo Therapeutics Inc APVO earned a $10 million non-dilutive milestone payment related to 2021 sales of Ruxience, under the terms of its royalty more_horizontal

Why Are Aptevo Therapeutics Shares Trading Higher Today?

By Benzinga
February 9, 2022

Why Are Aptevo Therapeutics Shares Trading Higher Today?

Aptevo Therapeutics Inc APVO earned a $10 million non-dilutive milestone payment related to 2021 sales of Ruxience, under the terms of its royalty more_horizontal

Why Are Aptevo Therapeutics Shares Trading Higher Today?

By Benzinga
February 9, 2022

Why Are Aptevo Therapeutics Shares Trading Higher Today?

Aptevo Therapeutics Inc APVO earned a $10 million non-dilutive milestone payment related to 2021 sales of Ruxience, under the terms of its royalty more_horizontal


Search within

Pages Search Results: